EGFR and non-small cell lung carcinoma: Second, in agreement with the publication of landmark studies and national practice guidelines, different members in multidisciplinary NSCLC care teams at our center, including medical oncologists, pulmonologists, thoracic surgeons, and pathologists, agreed to the importance of improving the clinical performance of EGFR mutation testing.